Reuters exclusively reports PAI Partners close to acquiring France's SGD Pharma - Reuters News Agency
Health

Reuters exclusively reports PAI Partners close to acquiring France’s SGD Pharma

Reuters reported exclusively that private equity firm PAI Partners is in final talks to buy France’s SGD Pharma, a firm that makes the vials used to store COVID-19 vaccines. According to a Reuters source, the transaction was expected to value SGD Pharma at around 10 times its core earnings, which stood at approximately 90 million euros ($109.15 million) last year. The deal was officially announced nine hours after the Reuters report was published. 

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: EquitiesPharmaceuticals & Healthcare
Regions: Europe
Countries: France
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story
FILE PHOTO: A small bottle labeled with a
Sign up for email updates
Subscribe
Sign up for email updates